MatchaDB

2018学術論文無料で読める

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.

Bonuccelli G, Sotgia F, Lisanti MP

Aging

出版社で読む→無料の全文→PubMedPubMed Central

要旨

Matcha green tea (MGT) is a natural product that is currently used as a dietary supplement and may have significant anti-cancer properties. However, the molecular mechanism(s) underpinning its potential health benefits remain largely unknown. Here, we used MCF7 cells (an ER(+) human breast cancer cell line) as a model system, to systematically dissect the effects of MGT at the cellular level, via i) metabolic phenotyping and ii) unbiased proteomics analysis. Our results indicate that MGT is indeed sufficient to inhibit the propagation of breast cancer stem cells (CSCs), with an IC-50 of ~0.2 mg/ml, in tissue culture. Interestingly, metabolic phenotyping revealed that treatment with MGT is sufficient to suppress both oxidative mitochondrial metabolism (OXPHOS) and glycolytic flux, shifting cancer cells towards a more quiescent metabolic state. Unbiased label-free proteomics analysis identified the specific mitochondrial proteins and glycolytic enzymes that were down-regulated by MGT treatment. Moreover, to discover the underlying signalling pathways involved in this metabolic shift, we subjected our proteomics data sets to bio-informatics interrogation via Ingenuity Pathway Analysis (IPA) software. Our results indicate that MGT strongly affected mTOR signalling, specifically down-regulating many components of the 40S ribosome. This raises the intriguing possibility that MGT can be used as inhibitor of mTOR, instead of chemical compounds, such as rapamycin. In addition, other key pathways were affected, including the anti-oxidant response, cell cycle regulation, as well as interleukin signalling. Our results are consistent with the idea that MGT may have significant therapeutic potential, by mediating the metabolic reprogramming of cancer cells.

要旨の文章はPubMed、OpenAlex、Europe PMCから取得したもので、著者と出版社に帰属します。

研究の種類

試験管内・細胞研究

細胞や単離した系での実験室実験。

タイトル、要旨、件名から自動的に割り当てています。

トピック

ここでは抹茶が主題のひとつです(タイトルに記載)。

キーワードと件名

あなたのリサーチフォルダー

この研究を引用する

Bonuccelli G, Sotgia F, Lisanti MP. (2018). Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways. Aging. https://doi.org/10.18632/aging.101483

DOI: 10.18632/aging.101483 · PubMed ID: 30153655 · 被引用75件(OpenAlex)

代謝と体重についてさらに

2018学術論文

Effect of tea products on the in vitro enzymatic digestibility of starch.

Zhang H, Jiang Y, Pan Jほか — Food chemistry

The importance of postprandial hyperglycemia in the treatment of diabetes has been recognized recently. Tea products, such as tea polyphenols (TP), epigallocatechin gallate (EGCG), matcha, and instant tea, were chosen as constituents of…

試験管内・細胞研究代謝と体重抗酸化物質とポリフェノール腸とマイクロバイオーム被引用76回
2020学術論文

Changes in Intestinal Microbiota of Type 2 Diabetes in Mice in Response to Dietary Supplementation With Instant Tea or Matcha.

Zhang HH, Liu J, Lv YJほか — Canadian journal of diabetes

Objective: Gut microbiota plays a key role in metabolism and health in diabetes patients with gastrointestinal microbiota dysbiosis. Thus, regulating the ecological balance of gut microbiota may provide a pathway toward improvement for…

動物研究代謝と体重腸とマイクロバイオーム市場・文化・持続可能性被引用74回
2023学術論文無料で読める

The therapeutic potential of matcha tea: A critical review on human and animal studies.

Sokary S, Al-Asmakh M, Zakaria Zほか — Current research in food science

Matcha is a powdered form of Japanese green tea that has been gaining global popularity recently. Matcha tea has various health benefits, including an enhancing effect on cognitive function, cardio-metabolic health, and anti-tumorogenesis.…

レビュー認知機能・気分・ストレス代謝と体重心血管と血圧被引用71回

ライブラリ全体を見る→